Skip to content Skip to footer
Subscribe Now
NEWS

DeepCyte Secures $1.5M to Advance AI-Driven Single-Cell Toxicology in Drug Development

Shots: DeepCyte, a techbio startup focused on advancing AI-powered toxicology for drug development, has officially launched with $1.5 million in seed funding, introducing two solutions to help biopharma teams detect, predict, and understand drug toxicity in human cells at single-cell resolution DeepCyte's MetaCore, a high-throughput single-cell metabolomics platform, leverages laser-based sampling and mass spectrometry to…
12 hours ago

Read more

VIEWPOINTS

When Algorithms Decide Visibility: Ben Beckley, CEO of RevHealth on the Future of Pharma 

Shots:  AI is redefining visibility in pharma as it becomes the primary gateway to information, requiring companies to shift from content publishing to engineering discoverability with machine-readable, well-cited, and rapidly updated data to be included in AI-generated summaries  Integrated, structured evidence is now critical for success in AI-driven environments, demanding modular, metadata-rich, and consistent data…
4 days ago

Read more

VIEWPOINTS

From Denials to Decisions: Dr. Wael Khouli of Authsnap on AI-Powered Healthcare Appeals 

Shots:  Did you know that nearly 15–20% of healthcare claims in the U.S. are denied on first submission, creating billions of dollars in administrative costs and forcing providers into complex, time-consuming appeals processes that strain revenue cycles, clinical staff, and patient care continuity?    Authsnap is an AI healthcare technology company helps providers manage insurance denials and…
March 16, 2026

Read more

EVENTS

Post-Conference Highlights | 2026 ViVE | Feb 22–25 | Los Angeles, CA

ViVE 2026 in Los Angeles convened policymakers, health system executives, payers, technologists, investors, and founders at a pivotal moment for healthcare. Across three days, discussions moved decisively from digital ambition to operational accountability. As the official Media Partner, PharmaShots presents a comprehensive review of the sessions, speakers, and strategic insights that defined ViVE 2026. Day…
February 26, 2026

Read more